Contact Privacy DMCA

Robuta
https://www.businesswire.com/news/home/20240415842099/en/KBI-Biopharma-Appoints-Jean-Baptiste-Agnus-as-Chief-Business-Officer KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer KBI Biopharma Appoints Jean-Baptiste (JB) Agnus as Chief Business Officer jean baptistekbibiopharmaappointsagnus https://www.businesswire.com/news/home/20240401053397/en/KBI-Biopharma-Strengthens-Quality-and-Regulatory-Affairs-Expertise-with-Appointment-of-Chief-Quality-Officer KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief... Peter Carbone joins KBI Biopharma as Chief Quality Officer quality and regulatory https://www.businesswire.com/news/home/20220706005082/en/KBI-Biopharma-and-Selexis-Hold-Joint-Ribbon-Cutting-of-the-Expanded-State-of-the-Art-Facility-in-Geneva-Switzerland KBI Biopharma and Selexis Hold Joint Ribbon Cutting of the Expanded State-of-the-Art Facility in... KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, held a joint ribbon-cutting ceremony yesterday at their new state-of-the-art facilit... https://www.businesswire.com/news/home/20220706005084/nl KBI Biopharma en Selexis houden gezamenlijk het lint doorknippen van de uitgebreide ultramoderne... KBI Biopharma SA (KBI) en Selexis SA, beide JSR Life Sciences-bedrijven, hielden gisteren een gezamenlijke ceremonie om het lint door te knippen in hun nieuw... https://www.terrapinn.com/conference/cell-culture/exhibitor-kbi-biopharma.stm KBI Biopharma, exhibiting at | Cell Culture KBI Biopharma, exhibiting at - Europe's leading Cell Culture and Downstream Processing conference for upstream and downstream manufacture kbibiopharmaexhibitingcellculture https://www.biospace.com/kbi-biopharma-announces-subcontract-with-mapp-biopharmaceutical-on-sudan-ebolavirus-treatment KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment -... Jan 23, 2023 - KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment. mapp biopharmaceuticalsudan ebolaviruskbiannouncessubcontract https://analyticsportal.kbi.bio/ Standalone Services - KBI Biopharma KBI Stat web application standalone serviceskbibiopharma https://www.businesswire.com/news/home/20230123005147/nl KBI Biopharma kondigt onderaannemingscontract aan met Mapp Biopharmaceutical voor behandeling van... KBI Biopharma, Inc. (KBI), een JSR Life Sciences-bedrijf, heeft vandaag aangekondigd dat het een onderaannemingscontract is aangegaan met Mapp Biopharmaceuti... mapp biopharmaceuticalkbiaan